{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:43:34Z","timestamp":1792799014383,"version":"4.5.0"},"reference-count":39,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"unspecified","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Oxford Biomedical Research","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"https:\/\/ror.org\/00k27zs44","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Oxford CRUK Cancer Centre","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["226535\/Z\/22\/Z"],"award-info":[{"award-number":["226535\/Z\/22\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["BST00070"],"award-info":[{"award-number":["BST00070"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Balliol Jowett Society","award":["D4T00070"],"award-info":[{"award-number":["D4T00070"]}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"crossref","award":["RCCTI100019"],"award-info":[{"award-number":["RCCTI100019"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2024,3,31]]},"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:p>We describe three cases of critical acute myositis with myocarditis occurring within 22 days of each other at a single institution, all within 1\u2009month of receiving the initial cycle of the anti-PD-1 drug pembrolizumab. Analysis of T cell receptor repertoires from peripheral blood and tissues revealed a high degree of clonal expansion and public clones between cases, with several T cell clones expanded within the skeletal muscle putatively recognizing viral epitopes. All patients had recently received a COVID-19 mRNA booster vaccine prior to treatment and were positive for SARS-CoV2 Spike antibody. In conclusion, we report a series of unusually severe myositis and myocarditis following PD-1 blockade and the COVID-19 mRNA vaccination.<\/jats:p>","DOI":"10.1136\/jitc-2023-008151","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T02:45:15Z","timestamp":1714013115000},"page":"e008151","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Severe acute myositis and myocarditis on initiation of 6-weekly pembrolizumab post-COVID-19 mRNA vaccination"],"prefix":"10.1136","volume":"12","author":[{"given":"Robert A","family":"Watson","sequence":"first","affiliation":[{"name":"MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK"},{"name":"Department of Oncology, University of Oxford, Oxford, UK"},{"name":"Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyu","family":"Ye","sequence":"additional","affiliation":[{"name":"MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK"},{"name":"Department of Oncology, University of Oxford, Oxford, UK"},{"name":"Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea A","family":"Taylor","sequence":"additional","affiliation":[{"name":"MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK"},{"name":"Department of Oncology, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsita","family":"Jungkurth","sequence":"additional","affiliation":[{"name":"MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK"},{"name":"Department of Oncology, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalin","family":"Cooper","sequence":"additional","affiliation":[{"name":"MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK"},{"name":"Department of Oncology, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orion","family":"Tong","sequence":"additional","affiliation":[{"name":"MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK"},{"name":"Department of Oncology, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"James","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Shine","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Hofer","sequence":"additional","affiliation":[{"name":"Department of Neuro Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Jenkins","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Pell","sequence":"additional","affiliation":[{"name":"Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Ieremia","sequence":"additional","affiliation":[{"name":"Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Jones","sequence":"additional","affiliation":[{"name":"Oxford Centre for Histopathological Research, Oxford University Hospitals NHS Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Maldonado-Perez","sequence":"additional","affiliation":[{"name":"Oxford Centre for Histopathological Research, Oxford University Hospitals NHS Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian S D","family":"Roberts","sequence":"additional","affiliation":[{"name":"Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Coupe","sequence":"additional","affiliation":[{"name":"Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0167-1685","authenticated-orcid":false,"given":"Mark R","family":"Middleton","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Oxford, Oxford, UK"},{"name":"Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda J","family":"Payne","sequence":"additional","affiliation":[{"name":"Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7413-5002","authenticated-orcid":false,"given":"Benjamin P","family":"Fairfax","sequence":"additional","affiliation":[{"name":"MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK"},{"name":"Department of Oncology, University of Oxford, Oxford, UK"},{"name":"Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,4,24]]},"reference":[{"key":"2026052005155026000_12.4.e008151.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.07.004"},{"key":"2026052005155026000_12.4.e008151.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1802357"},{"key":"2026052005155026000_12.4.e008151.3","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/s41416-021-01310-3","article-title":"Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles","volume":"124","author":"Ye","year":"2021","journal-title":"Br J Cancer"},{"key":"2026052005155026000_12.4.e008151.4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01440"},{"key":"2026052005155026000_12.4.e008151.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1609214"},{"key":"2026052005155026000_12.4.e008151.6","doi-asserted-by":"crossref","unstructured":"Aldrich J , Pundole X , Tummala S , et al . Incidence and outcomes of immune checkpoint inhibitor-related Myositis. JCO 2020;38. doi:10.1200\/JCO.2020.38.15_suppl.e15128","DOI":"10.1200\/JCO.2020.38.15_suppl.e15128"},{"key":"2026052005155026000_12.4.e008151.7","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0196-7"},{"key":"2026052005155026000_12.4.e008151.8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217522"},{"key":"2026052005155026000_12.4.e008151.9","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-068665","article-title":"SARS-Cov-2 vaccination and myocarditis or myopericarditis: population based cohort study","volume":"375","author":"Husby","year":"2021","journal-title":"BMJ"},{"key":"2026052005155026000_12.4.e008151.10","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa2109730","article-title":"Myocarditis after BNT162b2 mRNA vaccine against COVID-19 in Israel","volume":"385","author":"Mevorach","year":"2021","journal-title":"N Engl J Med"},{"key":"2026052005155026000_12.4.e008151.11","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-069445","article-title":"Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericardi- tis following COVID-19 vaccination: living evidence syntheses and review","volume":"378","author":"Pillay","year":"2022","journal-title":"BMJ"},{"key":"2026052005155026000_12.4.e008151.12","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/S0140-6736(22)00791-7","article-title":"Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases","volume":"399","author":"Wong","year":"2022","journal-title":"The Lancet"},{"key":"2026052005155026000_12.4.e008151.13","doi-asserted-by":"crossref","unstructured":"Shelly S , Triplett JD , Pinto MV , et al . Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy. Brain Commun 2020;2. doi:10.1093\/braincomms\/fcaa181","DOI":"10.1093\/braincomms\/fcaa181"},{"key":"2026052005155026000_12.4.e008151.14","doi-asserted-by":"crossref","unstructured":"Watson RA , Tong O , Cooper R , et al . Immune checkpoint blockade sensitivity and progression- free survival associates with baseline Cd8+ T cell clone size and cytotoxicity. Sci Immunol 2021;6. doi:10.1126\/sciimmunol.abj8825","DOI":"10.1126\/sciimmunol.abj8825"},{"key":"2026052005155026000_12.4.e008151.15","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0734-6"},{"key":"2026052005155026000_12.4.e008151.16","unstructured":"Fairfax B , Taylor C , Watson R , et al . Genetic variation at Il7 provides mechanistic insights into toxicity to immune checkpoint blockad. Tech Rep Type: Article 2022;1531341. doi:10.21203\/rs.3.rs"},{"key":"2026052005155026000_12.4.e008151.17","doi-asserted-by":"publisher","DOI":"10.1007\/s00285-012-0589-7"},{"key":"2026052005155026000_12.4.e008151.18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102972","article-title":"Ultra-efficient sequencing of T cell receptor reper- toires reveals shared responses in muscle from patients with myositis","volume":"59","author":"Montagne","year":"2020","journal-title":"EBioMedicine"},{"key":"2026052005155026000_12.4.e008151.19","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30608-9"},{"key":"2026052005155026000_12.4.e008151.20","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004792","article-title":"Prognosis of immune checkpoint inhibitors-induced myocarditis: a case series","volume":"11","author":"Coustal","year":"2023","journal-title":"J Immunother Cancer"},{"key":"2026052005155026000_12.4.e008151.21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-490565"},{"key":"2026052005155026000_12.4.e008151.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.09.004"},{"key":"2026052005155026000_12.4.e008151.23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.056730"},{"key":"2026052005155026000_12.4.e008151.24","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-4083"},{"key":"2026052005155026000_12.4.e008151.25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.709360"},{"key":"2026052005155026000_12.4.e008151.26","doi-asserted-by":"publisher","DOI":"10.1038\/nm955"},{"key":"2026052005155026000_12.4.e008151.27","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200389"},{"key":"2026052005155026000_12.4.e008151.28","doi-asserted-by":"publisher","DOI":"10.1126\/science.291.5502.319"},{"key":"2026052005155026000_12.4.e008151.29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124059","article-title":"Upregulation of programmed death-1 and its ligand in cardiac injury models: interaction with gadd153","volume":"10","author":"Baban","year":"2015","journal-title":"PLoS One"},{"key":"2026052005155026000_12.4.e008151.30","doi-asserted-by":"crossref","unstructured":"Gradone A , Ma VT , Fecher LA , et al . Increased incidence of immune-mediated myocarditis in advanced skin malignancies treated with immune checkpoint inhibitors in the COVID-19 era. JCO 2022;40. doi:10.1200\/JCO.2022.40.16_suppl.2664","DOI":"10.1200\/JCO.2022.40.16_suppl.2664"},{"key":"2026052005155026000_12.4.e008151.31","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1111\/jdv.17760","article-title":"Severe necrotizing myopathy after COVID-19 vaccine with BNT162b2 and regimen with ipilimumab plus nivolumab in a patient with advanced melanoma","volume":"36","author":"Blaise","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026052005155026000_12.4.e008151.32","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41419-023-05922-w","article-title":"SARS-Cov-2 infection and COVID-19 vaccination in cancer patients undergoing immune checkpoint inhibitors","volume":"14","author":"Yang","year":"2023","journal-title":"Cell Death Dis"},{"key":"2026052005155026000_12.4.e008151.33","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001870","article-title":"COVID-19 lung injury as a primer for immune checkpoint inhibitors (icis)-related pneumonia in a patient affected by squamous head and neck carcinoma treated with PD-L1 blockade: a case report","volume":"9","author":"Dipasquale","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2026052005155026000_12.4.e008151.34","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13443"},{"key":"2026052005155026000_12.4.e008151.35","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02095-5"},{"key":"2026052005155026000_12.4.e008151.36","doi-asserted-by":"publisher","DOI":"10.1038\/S41591-022-02094-6"},{"key":"2026052005155026000_12.4.e008151.37","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(21)00155-8"},{"key":"2026052005155026000_12.4.e008151.38","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006246","article-title":"COVID-19 vaccination in patients with cancer receiving immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"11","author":"Ruiz","year":"2023","journal-title":"J Immunother Cancer"},{"key":"2026052005155026000_12.4.e008151.39","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05501-7"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2023-008151","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:16:20Z","timestamp":1779279380000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2023-008151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4,24]]},"published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10.1136\/jitc-2023-008151"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2023-008151","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4]]}}}